Trial Profile
Effect of high dose atorvastatin within 24 hours before elective percutaneous coronary intervention on periprocedural myocardial infarction in patients treated at Imam Khomeini hospital between September 2010 to March 2011 -
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Angina pectoris; Coronary disorders; Myocardial infarction
- Focus Therapeutic Use
- 12 Oct 2012 New trial record